Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)

被引:0
|
作者
Huang, Yao-Ting [1 ]
Foldi, Julia [1 ]
Xiao, Kun [1 ]
Chung, Dick [1 ]
Neofytos, Dionysios [1 ]
Kolitsopoulos, Yovanna [1 ]
Maloy, Molly [2 ]
Giralt, Sergio [2 ]
Papadopoulos, Esperanza [2 ]
Jakubowski, Ann A. [2 ]
Papanicolaou, Genovefa
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY 10021 USA
关键词
D O I
10.1016/j.bbmt.2014.11.480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
434
引用
收藏
页码:S302 / S303
页数:2
相关论文
共 50 条
  • [1] THE EFFECT OF DONOR CYTOMEGALOVIRUS (CMV) SEROLOGIC STATUS ON CMV REACTIVATION AND SURVIVAL IN PATIENTS UNDERGOING ALLOGENIC STEM CELL TRANSPLANTATION
    Vega, J.
    Vatca, M.
    Mikulandric, N.
    Neme, K.
    Hanbali, A.
    Janakiraman, N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 109 - 109
  • [2] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
  • [3] Cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (SCT)
    Trenschel, R
    Ross, S
    Runde, V
    Retzlaff, S
    Ottinger, H
    Kohl, D
    Roggendorf, M
    Schaefer, UW
    BONE MARROW TRANSPLANTATION, 1999, 23 : S68 - S68
  • [4] Effect of the donor CMV status on CMV reactivation after allogeneic transplantation
    Nürnberger, W
    Krempe, C
    Steinhagen, G
    Adams, O
    Göbel, U
    BONE MARROW TRANSPLANTATION, 1999, 23 : S66 - S66
  • [5] Generation and administration of CMV pp65-specific donor T-cell lines for treatment of CMV reactivation after allogeneic stem cell transplantation
    Meij, P.
    Zandvliet, M. L.
    van der Heiden, P. L. J.
    Jedema, I.
    Egmond, E. M.
    Cox, L. M. P.
    de Meent, M. van
    Bongaerts, R.
    Hoogstraten, C.
    Guchelaar, H. J.
    Willemze, R.
    Falkenburg, J. H. F.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S28 - S29
  • [6] Risk Factors for Recurrent CMV Reactivation in CMV Seropositive Recipients Following T Cell Depleted Haematopoietic Stem Cell Transplantation
    Ibrahim, Abeer
    Ingram, Wendy
    Price, Nicola
    Davies, David
    Wilson, Keith
    BLOOD, 2014, 124 (21)
  • [7] Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
    Chen, George
    Zhang, Yali
    Tario, Joseph Dennis
    Herko, Amanda
    Pan, Przespolewski Dalin
    Mellors, Patrick
    Ho, Christine
    Balderman, Sophia R.
    Ross, Maureen
    Brix, Liselotte
    Wallace, Paul K.
    McCarthy, Philip L.
    Hahn, Theresa
    BLOOD, 2017, 130
  • [8] The applicability of cellular immunotherapy to cytomegalovirus (CMV): A retrospective study of allogeneic stem cell transplants (SCT) and CMV reactivation
    Diamanti, P.
    Garland, R. J.
    Groves, S. J.
    Nolan, R.
    Carrington, D.
    Marks, D. I.
    Robinson, S. P.
    Goulden, N. J.
    Cornish, J. M.
    Pamphilon, D. H.
    Blair, A.
    Steward, C. G.
    CYTOTHERAPY, 2006, 8
  • [9] Risk factors for CMV reactivation after T-cell depleted allogeneic bone marrow transplantation.
    Lin, TS
    Zahrieh, D
    Weller, E
    Alyea, ER
    Fisher, DC
    Gribben, JG
    Freedman, AS
    Schlossman, RL
    Lee, SJ
    Antin, JH
    Ritz, J
    Soiffer, RJ
    BLOOD, 2001, 98 (11) : 480A - 481A
  • [10] Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
    Servais, S.
    Dumontier, N.
    Biard, L.
    Schnepf, N.
    Resche-Rigon, M.
    de Latour, R. Peffault
    Scieux, C.
    Robin, M.
    Meunier, M.
    Xhaard, A.
    de Fontbrune, F. Sicre
    Le Goff, J.
    Socie, G.
    Simon, F.
    Mazeron, M. -C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (03) : 289.e1 - 289.e7